NASDAQ:ESPR Shareholder Notice: Lawsuit Alleges Misleading Statements by Esperion Therapeutics, Inc
An investor, who purchased shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR), filed a lawsuit over alleged violations of Federal Securities Laws by Esperion Therapeutics, Inc.
View full press release